Literature DB >> 8931830

Comparison of target organ damage in renovascular and essential hypertension.

A Losito1, R M Fagugli, I Zampi, B Parente, P de Rango, G Giordano, P Cao.   

Abstract

In many reports, the prevalence of target organ damage in renovascular hypertension (RVH) appears to be higher than in essential hypertension (EH). Since in most studies the renal artery stenosis is part of a diffuse atherosclerotic disease, it is not known whether these complications are due to RVH itself or to the vascular disease. We have undertaken a case control study of 92 patients divided into two groups (46 in each), one with RVH and the other with EH and abdominal aortic aneurysm, with a comparable degree of diffuse atherosclerotic vascular disease. The vascular state of the extracranial carotid arteries and abdominal and inferior limb districts was investigated with angiography and sonography. The prevalence of left ventricular hypertrophy (LVH) and ischemic heart disease (IHD) were assessed by electrocardiography. Serum creatinine and urinary protein excretion were employed in the renal evaluation. While the analysis of the results confirmed an even diffusion of atherosclerotic vascular disease between the two groups, a significant difference was found in the prevalence of heart and renal damage. LVH was present in 32.6% of RVH patients versus 10.8% in EH (P = .02). Serum creatinine > 1.4 mg/dL was found in 50% of RVH and in 23.9% of EH, (P = .01). The prevalence of proteinuria in RVH was also higher although not reaching the statistical significance. The results suggest that, in patients with comparable degrees of atherosclerotic vascular disease, RVH is responsible for the higher prevalence of target organ damage in this condition compared to those with EH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931830     DOI: 10.1016/0895-7061(96)00199-9

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  17 in total

Review 1.  Renovascular hypertension: screening and modern management.

Authors:  Iris Baumgartner; Lilach O Lerman
Journal:  Eur Heart J       Date:  2011-01-27       Impact factor: 29.983

2.  Inflammatory and injury signals released from the post-stenotic human kidney.

Authors:  Alfonso Eirin; Monika L Gloviczki; Hui Tang; Mario Gössl; Kyra L Jordan; John R Woollard; Amir Lerman; Joseph P Grande; Stephen C Textor; Lilach O Lerman
Journal:  Eur Heart J       Date:  2012-07-06       Impact factor: 29.983

3.  Autophagy Portends the Level of Cardiac Hypertrophy in Experimental Hypertensive Swine Model.

Authors:  Xin Zhang; Matthew E Gibson; Zi-Lun Li; Xiang-Yang Zhu; Kyra L Jordan; Amir Lerman; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2015-04-22       Impact factor: 2.689

4.  Valsartan regulates myocardial autophagy and mitochondrial turnover in experimental hypertension.

Authors:  Xin Zhang; Zi-Lun Li; John A Crane; Kyra L Jordan; Aditya S Pawar; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2014-04-21       Impact factor: 10.190

Review 5.  Renal Arterial Disease and Hypertension.

Authors:  Stephen C Textor
Journal:  Med Clin North Am       Date:  2017-01       Impact factor: 5.456

Review 6.  Renovascular hypertension and ischemic nephropathy.

Authors:  Stephen C Textor; Lilach Lerman
Journal:  Am J Hypertens       Date:  2010-09-23       Impact factor: 2.689

7.  Preserved function of late-outgrowth endothelial cells in medically treated hypertensive patients under well-controlled conditions.

Authors:  Zhi Chen; Sandra M S Herrmann; Xiangyang Zhu; Kyra L Jordan; Monika L Gloviczki; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Hypertension       Date:  2014-07-21       Impact factor: 10.190

8.  Cardiac metabolic alterations in hypertensive obese pigs.

Authors:  Xin Zhang; Zi-Lun Li; Alfonso Eirin; Behzad Ebrahimi; Aditya S Pawar; Xiang-Yang Zhu; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2015-06-15       Impact factor: 10.190

Review 9.  Clinical practice. Renal-artery stenosis.

Authors:  Lance D Dworkin; Christopher J Cooper
Journal:  N Engl J Med       Date:  2009-11-12       Impact factor: 91.245

Review 10.  [Hypertension in patients with renal artery stenosis].

Authors:  A Voiculescu; L C Rump
Journal:  Internist (Berl)       Date:  2009-01       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.